← Leaderboards
Brian C Jensen
Univ Of North Carolina Chapel Hill
$5,838,837
Attributed
$5,838,837
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,838,837 · 3
By mechanism
R01$5,176,187 · 2
K08$662,650 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Christin E Burd$5,593,902
- Christoph Daniel Rau$2,447,802
- Kimberly Lukasik$81,222
- Mark Allen Rossi$2,379,662
- Matthew Elwood Combs$107,010
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCardiacMouse ModelHeartCardiac MyocytesHeart FailureToxic EffectAgonistMolecularKnockout MiceCessation Of LifeCoupledIn VivoIn VitroOxidative PhosphorylationRegulationExperimental StudyClinically RelevantMitochondriaFunctional DisorderImpairmentMyocardialInjuryResearch Personnel
Grant awards (16)
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$547,890
R01 · FY2025 · HL · contact PI
Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity$519,681
R01 · FY2025 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$536,932
R01 · FY2024 · HL · contact PI
Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity$509,288
R01 · FY2024 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$585,090
R01 · FY2023 · HL · contact PI
Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity$533,556
R01 · FY2023 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$388,750
R01 · FY2022 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$388,750
R01 · FY2021 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$388,750
R01 · FY2020 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$388,750
R01 · FY2019 · HL · contact PI
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation$388,750
R01 · FY2018 · HL · contact PI
Alpha-1-Adrenergic Receptor Subtypes in the Cells of the Human Heart$132,422
K08 · FY2013 · HL · contact PI
Alpha-1-Adrenergic Receptor Subtypes in the Cells of the Human Heart$132,422
K08 · FY2012 · HL · contact PI
Alpha-1-Adrenergic Receptor Subtypes in the Cells of the Human Heart$132,422
K08 · FY2011 · HL · contact PI
Alpha-1-Adrenergic Receptor Subtypes in the Cells of the Human Heart$132,422
K08 · FY2010 · HL · contact PI
Alpha-1-Adrenergic Receptor Subtypes in the Cells of the Human Heart$132,962
K08 · FY2009 · HL · contact PI